Breaking news

Apple Ordered To Remit $634 Million For Patent Infringement

by THEFUTURE.TEAM

November 17, 2025

Apple Inc. now faces a staggering $634 million judgment after a California federal jury found the tech giant infringed on Masimo’s patent regarding blood oxygen monitoring technology.

Landmark Intellectual Property Ruling

The verdict, reported by Reuters, centers on the Apple Watch’s workout and heart rate notification features, which the jury determined unlawfully incorporated Masimo’s patented pulse oximetry innovations. According to Masimo, a leader in medical device technology (Masimo), this legal win is a critical measure to safeguard their technological advancements that directly benefit patient care.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Strategic Implications For Apple

An Apple spokesperson noted plans to appeal the decision, contesting that the patent in question expired in 2022 and dated back to outdated patient monitoring methods. This response underscores a broader debate over legacy technologies versus evolving innovation paradigms.

Broader Context Of The Dispute

The contentious legal battle extends beyond patent infringement alone. Masimo has previously accused Apple of recruiting its talent, including the company’s chief medical officer, to leverage its pulse oximetry expertise. The United States International Trade Commission further bolstered Masimo’s stance in 2023 by banning Apple from importing devices featuring blood oxygen monitoring capabilities—a cautionary precedent that has prompted Apple to re-engineer the function to operate on the paired iPhone rather than the watch.

Counterlitigation And Ongoing Legal Challenges

As the litigation landscape evolves, Masimo is also challenging U.S. Customs and Border Patrol for approving the new Apple Watch imports, while Apple has escalated its contest to higher courts, seeking reversal of the import ban. In a related development, Apple secured a $250 statutory minimum in a countersuit after a jury found Masimo had infringed on its design patents.

This case not only highlights the high stakes involved in protecting intellectual property but also reflects the broader tensions at the intersection of innovation, talent acquisition, and competitive market dynamics in the technology sector.

The Future Forbes Realty Global Properties

Meta’s Reality Labs Deepens Its Losses Even As Revenue Climbs

Meta Platforms’ Reality Labs division reported an operating loss of $4.62 billion in the second quarter, highlighting the continued cost of the company’s investments in virtual and augmented reality technologies. The unit generated revenue of $431 million, up from $370 million a year earlier and above analysts’ expectations of $423.4 million, according to StreetAccount. Operating losses widened from $4.53 billion in the same quarter of 2025.

Revenue Grows As Losses Continue

Despite higher revenue, Reality Labs remains one of Meta’s biggest cost centres. Since late 2020, the division has accumulated more than $80 billion in operating losses as the company continues investing in hardware and software for its long-term computing strategy.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Focus Shifts Toward AI Wearables

Reality Labs develops the Quest virtual reality headsets and Ray-Ban Meta smart glasses in partnership with EssilorLuxottica. While Meta originally positioned the division around its metaverse vision, the company has increasingly focused on AI-powered wearables as demand for virtual reality devices has grown more slowly than expected.

Long-Term Investment

Meta renamed Facebook to Meta in 2021 to reflect its strategy of expanding beyond social media through immersive technologies. Although Reality Labs continues to report multi-billion-dollar quarterly losses, Zuckerberg has maintained that investments in AI, wearable devices and next-generation computing platforms are central to the company’s long-term growth strategy.